Rozglyn-MP1 Tablet 10's
₹116.1*
MRP ₹129
10% off
₹110*
MRP ₹129
15% CB
₹19 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Rozglyn-MP1 Tablet belongs to a class of medicines called anti-diabetic drugs used in the treatment of type 2 diabetes, especially in patients whose blood sugar levels are not controlled by diet and exercise alone. Type 2 diabetes is a chronic (long-lasting) condition that affects the way our body processes glucose. People with type 2 diabetes either do not produce enough insulin or the insulin produced is unable to perform its function in the body (insulin resistance).
Rozglyn-MP1 Tablet is a combination of three antidiabetic drugs, namely: Glimepiride, Metformin, and Pioglitazone. Glimepiride works by stimulating beta cells in the pancreas that produce insulin. Thus, insulin helps to remove sugar from the blood. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood. Pioglitazone works by increasing the sensitivity of liver, muscle, and fat cells to insulin and enables cells to remove glucose from blood more effectively. Thereby, Rozglyn-MP1 Tablet helps to control blood sugar levels.
Take Rozglyn-MP1 Tablet as prescribed by your doctor. You are advised to take Rozglyn-MP1 Tablet for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience stomach pain, nausea, diarrhoea, vomiting, headache, metallic taste, or low blood sugar. Most of these side effects of Rozglyn-MP1 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Rozglyn-MP1 Tablet or any other medicines, please tell your doctor. Rozglyn-MP1 Tablet is not recommended for children. Avoid breastfeeding while taking Rozglyn-MP1 Tablet as it may be excreted in human milk. If you are pregnant or planning for pregnancy, please inform your doctor before taking Rozglyn-MP1 Tablet as it may harm the unborn baby. Rozglyn-MP1 Tablet should be used with caution in elderly patients. Avoid alcohol consumption with Rozglyn-MP1 Tablet as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body). Drive only if you are alert after taking Rozglyn-MP1 Tablet .
Rozglyn-MP1 Tablet contains three antidiabetic drugs (Glimepiride, Metformin and Voglibose) used in the treatment of type 2 diabetes. Glimepiride stimulates cells in the pancreas that produce insulin which helps to remove sugar from the blood. Metformin reduces the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood. Pioglitazone works by increasing the sensitivity of liver, muscle and fat cells to insulin and enables cells to remove glucose from blood more effectively. Also, it decreases the amount of glucose produced by the liver and preserves the functioning of beta cells in the pancreas that produces insulin. Thereby, Rozglyn-MP1 Tablet helps to control blood sugar levels.
If you are allergic to Rozglyn-MP1 Tablet or any other medicines, please tell your doctor. Rozglyn-MP1 Tablet is not recommended for children. Avoid breastfeeding while taking Rozglyn-MP1 Tablet as it may be excreted in human milk. If you are pregnant or planning for pregnancy, please inform your doctor before taking Rozglyn-MP1 Tablet as it may harm the unborn baby. Rozglyn-MP1 Tablet should be used with caution in elderly patients. Avoid alcohol consumption with Rozglyn-MP1 Tablet as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body). Drive only if you are alert after taking Rozglyn-MP1 Tablet . Take short, frequent meals and avoid prolonged fasting while taking Rozglyn-MP1 Tablet . Beware of symptoms of hypoglycemia (low blood sugar) which include sweating, dizziness, palpitations, shivering, intense thirst, dry mouth, dry skin, frequent urination, etc. Whenever you experience any of these symptoms, immediately consume 5-6 candies or 3 glucose biscuits, or 3 teaspoons of honey/sugar, and also consult your doctor. Make sure to carry these with you at all times, especially during long travels.
Drug-Drug Interaction: Rozglyn-MP1 Tablet may have interaction with other antidiabetic drugs (insulin, sitagliptin, empagliflozin), water pill (furosemide), antithyroid drugs (levothyroxine), anticonvulsant (pregabalin).
Drug-Food Interaction: Rozglyn-MP1 Tablet may interact with alcohol. Therefore, avoid the consumption of alcohol with Rozglyn-MP1 Tablet as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body).
Drug-Disease Interaction: If you have bladder cancer, uncontrolled diabetes, lactic acidosis, diabetic ketoacidosis (accumulation of ketone bodies in the blood), or eye problems caused by diabetes, liver, kidney, or heart problems, inform your doctor before taking Rozglyn-MP1 Tablet .
Do regular exercise such as cycling, walking, jogging, dancing or swimming for a minimum of 30 minutes per day. Invest at least 150 minutes of your week in exercise.
Maintain healthy body weight as obesity is also related to the onset of diabetes.
Maintain a low fat and a low sugar diet. Replace carbohydrates-containing foods with whole grains, fruits and vegetables as carbohydrates turn to sugars leading to high blood sugar.
Avoid consumption of alcohol and quit smoking.
Regular blood tests are recommended while taking Rozglyn-MP1 Tablet to monitor blood sugar levels.
Type 2 diabetes: It is a chronic (long-lasting) condition that keeps the body away from properly utilizing insulin. Hence, people affected with type 2 diabetes either do not produce enough insulin, or there is resistance to the action of insulin. Middle-aged or older are most likely to suffer from type 2 diabetes, so it is also known as adult-onset diabetes. Symptoms of type 2 diabetes include frequent urination at night, increased thirst, slow wound healing, increased hunger, fatigue, and blurred vision. In some cases, there may be weight gain while in rare cases weight loss may be observed. The complication of type 2 diabetes also includes nerve problems, kidney problems, damaged retina of eyes or blindness, loss of limbs, sexual dysfunction, and increase chance of heart attack or stroke.
Alcohol
Unsafe
You are recommended to avoid consumption of alcohol with Rozglyn-MP1 Tablet as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body).
Pregnancy
Unsafe
Rozglyn-MP1 Tablet is not recommended for pregnant women as it may harm an unborn baby. Please consult a doctor if you are pregnant or planning for pregnancy.
Breast Feeding
Unsafe
Avoid breastfeeding while taking Rozglyn-MP1 Tablet as it may be excreted in breastmilk and cause adverse effects in the baby. Therefore, please consult a doctor before using Rozglyn-MP1 Tablet if you are breastfeeding.
Driving
Caution
Rozglyn-MP1 Tablet may decrease alertness in some people. Therefore, drive only if you are alert after taking Rozglyn-MP1 Tablet .
Liver
Caution
Take Rozglyn-MP1 Tablet with caution, especially if you have a history of Liver diseases/conditions. The dose may be adjusted by your doctor as required.
Kidney
Caution
Take Rozglyn-MP1 Tablet with caution, especially if you have a history of Kidney diseases/conditions. The dose may be adjusted by your doctor as required.
Children
Unsafe
Rozglyn-MP1 Tablet is not recommended for children as the safety and effectiveness were not established.
Country of origin
We provide you with authentic, trustworthy and relevant information
Product Substitutes